Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.

被引：23

作者：

Hong, David S.

Shen, Lin

van Tilburg, Cornelis Martinus

Tan, Daniel Shao-Weng

Kummar, Shivaani

Lin, Jessica Jiyeong

Doz, Francois P.

McDermott, Raymond S.

Albert, Catherine M.

Berlin, Jordan

Bielack, Stefan S.

Lassen, Ulrik Niels

Tahara, Makoto

Norenberg, Ricarda

Shurshalina, Anna

Fellous, Marc Mardoche

Nogai, Hendrik

Xu, Rui-hua

Laetsch, Theodore Willis

Drilon, Alexander E.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China

[3] Heidelberg Univ Hosp, Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, Heidelberg, Germany

[5] Natl Canc Ctr Singapore, Singapore, Singapore

[6] OHSU, Knight Canc Inst, Portland, OR USA

[7] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] Inst Curie, Paris, France

[10] Univ Paris, Paris, France

[11] St Vincents Univ Hosp, Dublin, Ireland

[12] Canc Trials Ireland, Dublin, Ireland

[13] Seattle Childrens Hosp, Seattle, WA USA

[14] Univ Washington, Sch Med, Seattle, WA USA

[15] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[16] Klinikum Stuttgart Olgahosp, Stuttgart, Germany

[17] Rigshosp, Dept Oncol, Copenhagen, Denmark

[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[19] Chrestos Concept GmbH & Co KG, Essen, Germany

[20] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[21] Bayer HealthCare Pharmaceut Inc, Basel, Switzerland

[22] Bayer AG, Wuppertal, Germany

[23] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China

[24] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[25] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[26] Weill Cornell Med Coll, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3108

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3108

引用

页数：2

共 50 条

[1] Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer
Leyvraz, S.
Hong, D. S.
Shen, L.
van Tilburg, C. M.
Tan, D. S. W.
Kummar, S.
Lin, J. J.
Doz, F.
McDermott, R.
Albert, C. M.
Berlin, J.
Bielack, S.
Lassen, U. N.
Tahara, M.
Norenberg, R.
Shurshalina, A.
Fellous, M.
Nogai, H.
Xu, R.
Laetsch, T. W.
Drilon, A.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 13 - 13
[2] Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.
Drilon, Alexander E.
Kummar, Shivaani
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Moreno, Victor
Leyvraz, Serge
Dubashi, Biswajit
Haresh, K. P.
Burcoveanu, Domnita-Ileana
Neu, Natascha
Mussi, Chiara E.
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[3] Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Patel, Jyoti D.
Rosen, Lee S.
Solomon, Benjamin Maurice
Norenberg, Ricarda
Dima, Laura
Brega, Nicoletta
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[4] Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer.
Hong, David S.
Drilon, Alexander E.
Tan, Daniel Shao-Weng
Lin, Jessica Jiyeong
Kummar, Shivaani
McDermott, Raymond S.
Berlin, Jordan
Italiano, Antoine
Lassen, Ulrik Niels
Leyvraz, Serge
Tahara, Makoto
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Brega, Nicoletta
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[5] Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer.
Drilon, Alexander E.
Hong, David S.
Van Tilburg, Cornelis Martinus
Doz, Francois
Tan, Daniel S. W.
Kummar, Shivaani
Lin, Jessica Jiyeong
McDermott, Raymond S.
Zwaan, C. Michel
Norenberg, Ricarda
Fellous, Marc Mardoche
Brega, Nicoletta
Xu, Rui-Hua
Laetsch, Theodore Willis
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[6] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset
Garralda, E.
Hong, D.
Xu, R.
Deeken, J.
Italiano, A.
Liu, T.
Ferrandiz, A.
Patel, J.
Lee, D.
Chung, H.
Kinoshita, I.
Berlin, J.
Andre, T.
Oh, D.
Leyvraz, S.
Miguel, M.
Liu, Y.
Norenberg, R.
Fellous, M.
Mussi, C.
Drilon, A.
Shen, L.
ANNALS OF ONCOLOGY, 2022, 33 : S370 - S370
[7] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Kummar, Shivaani
Patel, Jyoti D.
Cermignani, Luciano
Dai, Ming-Shen
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Rosen, Lee S.
Saada-Bouzid, Esma
Solomon, Benjamin Maurice
Xu, Rui-Hua
Yachnin, Jeffrey
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Mussi, Chiara E.
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Rieke, D. T.
Lin, Iyeong J.
Tan, D. S.
Kummar, S.
Patel, J. D.
Cermignani, L.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Moreno, V.
Rosen, L.
Saada-Bouzid, E.
Solomon, B.
Xu, R. -H.
Yachnin, J.
Norenberg, R.
Burcoveanu, D. -I.
Mussi, C. E.
Shen, L.
Drilon, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 9 - 10
[9] Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion Cancer
Rieke, D. T.
Hong, D. S.
Drilon, A.
Tan, D. S.
Lin, J.
Kummar, S.
McDermott, R.
Berlin, J.
Italiano, A.
Lassen, U. N.
Leyvraz, S.
Tahara, M.
Norenberg, R.
Burcoveanu, D. -I.
Brega, N.
Shen, L.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 142 - 143
[10] Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
McDermott, R.
van Tilburg, C. M.
Farago, A. F.
Kummar, S.
Tan, D. S. W.
Albert, C. M.
Berlin, J.
Lassen, U. N.
Doz, F.
Geoerger, B.
Mascarenhas, L.
Federman, N.
Reeves, J. A.
Dima, L.
Brega, N.
De La Cuesta, E.
Laetsch, T. W.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2020, 31 : S1101 - S1102

← 1 2 3 4 5 →